Fujifilm is building a $36 million “smart” manufacturing facility in Tochigi, Japan, to double its endoscope production capability.
EndoGastric Solutions closed a $45 million series I round to fuel commercialization efforts around its TIF 2.0 procedure.
A phase 1 clinical trial found that Landos Biopharma’s Crohn’s disease and ulcerative colitis treatment, BT-11, was well-tolerated with no dose-limiting toxicities or detectable systemic immunosuppression.
More articles on gastroenterology:
Now-defunct Laser Spine Institute under fire over insurance handling — 5 key details
Washington passes surprise-billing law
3 ways ASCs can improve cash flow
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
